The immune system attempts to prevent or limit
Figure 2
Chemokine expression by primary melanoma cells and TIL. (a) Chemokine expression in 48 hr-conditioned medium from established melanomas, melanoma cell lines, and TIL were analyzed for CCL2, 3, 5, and CXCL12 production. Results show the mean Ϯ SD of triplicates from one representative experiment of the five performed. (b) CCL5 production by TIL that were stimulated 48 hr with conditioned medium from primary MEL#1 melanoma, SK29-MEL cells, or chemokines (CCl2 and CXCL12) was assessed. CCL5 concentration in AIM-V medium and CCL5 upregulation in unstimulated TIL that were cultured for 48 hr (Medium) are shown as controls. The effect of anti-CXCL12 antibody on melanoma-induced chemokine upregulation is shown.
action and successful immune responses, they collaborate A major conundrum in cancer is that the presence of TIL does not result in cancer cell elimination [3] . We used a to establish the conditions that precede the immune response [9] . human malignant melanoma model to study the mechanisms underlying the lack of tumor rejection. Melanoma lines and infiltrating CD8 ϩ T cells from several melanoma CCL5 is a chemokine that interacts with the G proteincoupled receptors (GPCR) CCR1, CCR3, CCR4, and patients were derived in vitro. TIL that were cultured in the presence of melanoma cells underwent cell death, as CCR5 [11] . It is a potent chemoattractant for CD4 ϩ and CD8 ϩ lymphocytes as well as for monocytes, NK cells, assessed by cellular DNA staining with the DNA intercalator propidium iodide (PI), and evaluation of the percentand eosinophils [11] . A close relationship has been established between the induction of HIV-1-specific cytotoxicage of DNA in the hypodiploid subG 0 /G 1 cell cycle peak (Figure 1a ) or by the detection of apoptotic nuclei using ity and the CCL5 effect via CCR3 [12, 13] . In addition, using human peripheral blood lymphocytes (PBL), malig-TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) after Hoechst staining (Fignant T cells, and CD4/CXCR4 transfectants, the active role of CXCR4 has been described in the rapid, CD95-ure 1b). Cell death is observed 16 hr after the initiation of coculture, reaching a maximum at 48 hr. TIL death independent cell death of CD4 ϩ T cells [14] . Increased CCL5 expression by breast carcinomas correlates with requires the presence of freshly explanted melanomas, since culture-adapted melanoma lines, such as SK29-enhanced tumor progression [15] . These studies suggest that chemokines also participate in activating the apo-MEL, are unable to trigger apoptosis ( Figures 1a,b and S1a). Similar results were obtained in experiments using ptotic cell death pathway. Here, we establish a link between the ability of chemokines to promote tumor proprimary melanoma cell lines derived from seven patients.
To determine whether tumor-TIL cell contact was necesgression and the prevention of tumor elimination by the immune system. The results show CXCL12-mediated sary, experiments were performed using conditioned medium from a melanoma cell line (SK29-MEL) or fresh upregulation of CCL5 production by TIL. CCL5 binding to CCR5 promotes specific CCR5 cell death via activation melanoma cells (MEL#1) to induce TIL cell death. No significant cell death was observed when SK29-MELof a cytochrome c-dependent pathway in the infiltrating cells, the consequence of which is tumor cell escape from conditioned medium was used, whereas MEL#1-conditioned medium induced cell death levels similar to those immune system control. induced by TIL coculture with fresh melanoma cells (Figure 1a) . No apoptosis was detected following TIL culture in fresh medium for the same period, indicating that the effect was due to a melanoma cell-released factor(s) in the medium.
Melanoma cells trigger CCL5 production by infiltrating lymphocytes
To characterize the molecules involved in this type of cell death, we analyzed surface proteins on TIL and melanomas. Using specific antibodies in flow cytometry, we detected Fas, TNFR-II, and TNF-␣ levels in both cell types, whereas no significant staining was seen using TNFR-I-and FasL-specific antibodies ( Figure S1b ). Further characterization included chemokine receptors and melanoma-specific markers. Neither TIL nor melanoma cells express surface CCR2, but both express CXCR4, and a significant percentage of the TIL population (30%-56%) expresses CCR5 (see Supplementary material).
This receptor expression pattern prompted analysis of the chemokines produced by both TIL and melanoma cells, as chemokines have been implicated in tumor growth [16] . Primary melanoma cells from several patients, but not the established melanoma cell lines SK-MEL-28, SK29-MEL, or A-375, produced elevated CCL2 (MCP-1) and CXCL12 levels, whereas TIL produced CCL3, 4, and 5 (Figure 2a ). This data was supported by the finding that TIL cocultures with fresh melanoma cells, but not with SK29-MEL or its conditioned medium, upregulated TIL CCL5 production (Figure 2b ). In determining whether the melanoma-produced chemokines were responsible for this effect, we found that CXCL12 (5 nM), but not CCL2 (5 nM), also upregulates CCL5 production by TIL (Figure 2b) . This finding concurs with the blocking effect of anti-CXCL12 antibodies on MEL#1-promoted CCL5 upregulation ( Figure 2b ). All together, these data suggest CCL5 induces cell death in TIL and PBL through a CCR5-and G that melanoma-secreted CXCL12 is responsible for the protein-dependent mechanism. (a) Melanoma-conditioned mediumupregulation of CCL5 production and subsequent effects. TIL death, indicating a CXCL12-induced, CCR5-mediated mechanism compatible with CXCL12-induced CCL5 upregulation. To further correlate cell death with chemokine production, TIL were incubated (24 hr) with several or 5 induced cell death (Figure 3b ), which is blocked by neutralizing anti-CCR5 mAb (Figure 3c ). CXCL12 concentrations (1-10 nM) of CXCL12 or CCL2, 3, 4, or 5. Whereas CCL2 did not promote cell death, incubation induced moderate TIL death (10%-15%) at 24 hr, which increased thereafter (Figure 3b) . Finally, the cell death for 24 hr with the CCR5-related chemokines CCL3, 4, triggered by MEL#1 and TIL coculture is blocked by anti-CXCL12 antibody and reconstituted by exogenous CCL5 addition (data not shown).
CCL5 triggers an apoptotic pathway involving cytochrome c release from mitochondria as well as caspase-8 and -3 activation CCL5 signaling is mediated by triggering receptor homodimerization, which recruits the JAK1 tyrosine kinase, and subsequent association of the G␣ i protein to the receptor complex [17] . Blocking this signal by treatment of TIL with pertussis toxin (PTx, which arrests G␣ i protein activation) or AG-490 (which inhibits JAK activation) prevents cell death induced by CCL5 or by melanoma-conditioned medium (Figure 3d ). This indicates that both G␣ i protein and JAK kinase activation are required to induce specific CCL5-mediated cell death in TIL, as neither PTx nor AG-490 block Fas ligation-induced cell death (data not shown). We thus conclude that the melanoma induces death in TIL by activating CCL5 production; this chemokine triggers an apoptotic pathway that requires chemokine receptor activation. This pathway is not exclusive to TIL but can also be triggered in PBL, in which CCL5 promotes specific depletion of CCR5-expressing cells, as determined by CCR5/annexin V staining ( Figure  3e ). This depletion is blocked by neutralizing anti-CCL5 Ab, anti-CCR5 mAb, or met-RANTES (Figure 3e ). Two main mechanisms have been proposed for apoptosis triggering; first, caspase-8 recruitment to death receptors (Fas or TNF) and second, cytochrome c release from mitochondria to the cytosol, followed by Apaf-1 recruitment, which activates caspase-9 and leads to cell death [18] . When TIL were maintained in culture, cytochrome c was localized in mitochondria (Figure 4a ), whereas when these cells were incubated with CCL5 or melanoma-conditioned medium, cytochrome c was released to the cytosol, as detected by immunofluorescence (Figure 4a ) or Western blot (Figure 4b ). As expected in the cytochrome c pathway, caspase-9 was activated, which is shown by the presence of the cleaved 30 kDa form (Figure 4c , upper panel), as was caspase 3, which is shown by the presence of the 17 kDa cleaved form (Figure 4c, middle panel) . Caspase-8 activation was not detected in CCL5-induced cell death (Figure 4c, lower panel) . We thus conclude that, CCL5 induces cytochrome c release and caspase-3 and -9 activity.
in TIL, CCL5 activates an apoptotic pathway triggered by infiltrating cells via the CCR5 receptor ( Figure S1c) .
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